Dr. Kermack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
804 E 138th St
Bronx, NY 10454Phone+1 718-665-7500
Education & Training
Dalhousie University Faculty of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2014 - 2025- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 3 citationsIs extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysi...John D. Roache, Martina Pavlicova, Aimee N.C. Campbell, Tse‐Hwei Choo, Michelle Peavy
Alcoholism, Clinical and Experimental Research. 2021-10-26 - 13 citationsExtended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).Mia Malone, Ryan McDonald, Alex Vittitow, Jenny Chen, Rita Obi
Contemporary Clinical Trials. 2019-06-01 - 53 citationsBuprenorphine prescribing practice trends and attitudes among New York providersAndrea Kermack, Mara Flannery, Babak Tofighi, Jennifer McNeely, Joshua D. Lee
Journal of Substance Abuse Treatment. 2017-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
